Avanos Medical, Inc. (NYSE:AVNS) Q3 2024 Earnings Call Transcript
Operator: Good morning, ladies and gentlemen, and welcome to the Avanos Medical, Avanos Third Quarter 2024 Earnings Call.
Avanos Medical Inc. (AVNS)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | RGM Capital Robert G. Moses | 3,171,455 | $76,210,064 | 3.29% | |
| 2. | Paradice Investment Management David Paradice | 1,262,249 | $30,331,843 | -7% | 5.27% |
| 3. | Arrowstreet Capital Peter Rathjens, Bruce Clarke And John Campbell | 454,931 | $10,931,992 | +369% | 0% |
| 4. | D E Shaw D. E. Shaw | 345,725 | $8,307,772 | -29% | 0% |
| 5. | AQR Capital Management Cliff Asness | 139,304 | $3,346,082 | -6% | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $19.85 | 500 | Director | 50,090 | 2024-03-11 | Filing | |
| $31.67 | 800 | Director | 33,900 | 2021-09-15 | Filing | |
| $31.65 | 900 | Director | 33,100 | 2021-09-15 | Filing | |
| $31.62 | 853 | Director | 32,200 | 2021-09-15 | Filing | |
| $31.61 | 2,447 | Director | 31,347 | 2021-09-15 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $19.16 | 110 | Officer | 151,495 | 2024-03-14 | Filing | |
| $19.15 | 808 | Officer | 151,605 | 2024-03-14 | Filing | |
| $19.14 | 337 | Officer | 152,413 | 2024-03-14 | Filing | |
| $19.13 | 2,231 | Officer | 152,750 | 2024-03-14 | Filing | |
| $19.12 | 714 | Officer | 154,981 | 2024-03-14 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 7,461,343 | $167,357,925 | 0% | |
| 2. | 5,417,952 | $121,524,663 | 0% | |
| 3. | 2,854,235 | $64,021,492 | 0.01% | |
| 4. | 1,962,876 | $44,027,309 | 0% | |
| 5. | 1,220,210 | $27,369,310 | 0.07% |
News See All
Avanos Medical, Inc. (NYSE:AVNS) Q2 2024 Earnings Call Transcript
Operator: Good morning, ladies and gentlemen, and welcome to the Avanos Medical Q2 2024 Earnings Call. At this time, all lines are in a listen-only mode.
Avanos Medical, Inc. (NYSE:AVNS) Q1 2024 Earnings Call Transcript
Operator: Good morning ladies and gentlemen and welcome to the Avanos First Quarter 2024 Earnings Conference. At this time, all lines are in a listen-only mode.
Avanos Medical, Inc. (NYSE:AVNS) Q4 2023 Earnings Call Transcript
Avanos Medical, Inc. misses on earnings expectations. Reported EPS is $0.32 EPS, expectations were $0.37.
Avanos Medical, Inc. (NYSE:AVNS) Q3 2023 Earnings Call Transcript
Operator: Good morning, and welcome to Avanos' Third Quarter 2023 Earnings Conference Call. All participants will be in listen-only mode.
Avanos Medical, Inc. (NYSE:AVNS) Q2 2023 Earnings Call Transcript
Operator: Good morning, everyone, and welcome to the Avanos Second Quarter 2023 Earnings Conference Call. All participants are in a listen-only mode.
Avanos Medical, Inc. (NYSE:AVNS) Q1 2023 Earnings Call Transcript
Operator: Good morning and welcome to the Avanos Q1 Earnings Conference Call. All participants will be in listen-only mode. Please note this event is being recorded.
Does Avanos Medical (AVNS) Have a Good Self-Help Strategy?
Heartland Advisors, an investment management company, released its “Heartland Value Plus Fund” first quarter 2023 investor letter. A copy of the same can be downloaded here.
Avanos Medical, Inc. (NYSE:AVNS) Q4 2022 Earnings Call Transcript
Operator: Good day. And welcome to the Avanos Fourth Quarter 2022 Earnings Conference Call. All participants will be in a listen-only mode.
Hedge Funds Are Piling Into Avanos Medical, Inc. (AVNS)
In this article we are going to use hedge fund sentiment as a tool and determine whether Avanos Medical, Inc. (NYSE:AVNS) is a good investment right now.